What does it do? Glutathione is a small protein composed of
three amino acids:
cysteine, glutamic acid, and glycine. Glutathione is involved in detoxification—it binds to
toxins, such as heavy metals, solvents, and pesticides, and transforms them into a form that
can be excreted in urine or bile. Glutathione is also an important antioxidant. In preliminary research, dietary glutathione
intake from fruit and raw vegetables has been associated with protection against some
forms of cancer.1 2 Glutathione
has also inhibited cancer in test tube3 and animal studies.4 In
preliminary research, higher glutathione levels have also been associated with good health in
older adults.5
Glutathione supplements appear to be efficiently absorbed in rats.6 7
However, the same may not be true for glutathione supplements in humans. For example, when
seven healthy subjects were given a single application of up to 3,000 mg of glutathione, there
was no increase in blood glutathione levels.8 The authors of the study concluded
“it is not feasible to increase circulating glutathione to a clinically beneficial
extent by the oral administrating of a single application of 3,000 mg of glutathione.”
Absorption of glutathione may be better in rats because unlike the gastrointestinal tract of
rats, the human gastrointestinal tract contains significant amounts of an enzyme (gamma-glutamyltranspeptidase) that breaks down glutathione.
Very preliminary evidence has suggested that absorption of glutathione can occur in the mouth
when glutathione tablets are placed between the teeth and the inner cheek.9
Some researchers believe that supplements other than oral glutathione may be more effective
in raising blood levels of glutathione. For example, in one trial, blood glutathione levels
rose nearly 50% in healthy people taking 500 mg of vitamin
C per day for only two weeks.10 Vitamin C raises glutathione by helping the
body manufacture it. In addition to vitamin C, other nutritional compounds that may, according
to preliminary research, help increase glutathione levels include alpha lipoic acid,11 glutamine,12
methionine,13 S-adenosyl methionine
(SAMe),14 and whey protein.15
Vitamin B6,
riboflavin, and selenium are required in the
manufacture of glutathione. The extent to which any of these nutrients effectively increases
glutathione levels in humans remains unclear.
Studies using intravenous or intramuscular glutathione have found it to be useful for
preventing clot formation during operations;16 reducing the side effects and
increasing the efficacy of chemotherapy drugs
(particularly cisplatin in women with ovarian
cancer);17 18 treating
Parkinson’s disease;19 reducing blood pressure in people with diabetes with high blood
pressure;20 and increasing sperm counts in men with low sperm counts.21 22 A
glutathione nasal spray has also reduced symptoms in people with chronic rhinitis.23 Whether oral preparations are
also effective is unknown at this time. A small study in eight patients with liver cancer
using oral glutathione showed modest benefits in women, but not in men, when given in a daily
amount of 5,000 mg.24
An unpublished preliminary study of eight colon cancer patients also found that oral
glutathione appeared to have anticancer
activity.25 Nonetheless, because questions exist about the extent to which oral
glutathione can be absorbed, some doctors are concerned that oral preparations may be either
less effective than other forms or not effective at all.
References:
1. Sen CK. Nutritional biochemistry of cellular glutathione. Nutr
Biochem 1997;8:660–72.
2. Flagg EW, Coates RJ, Jones DP, et al. Dietary glutathione intake and
the risk of oral and pharyngeal cancer. Am J Epidemiol 1994;139:453–65.
3. Donnerstag B, Ohlenschläger, Cinatl J, et al. Reduced glutathione
and S-acetylglutathione as selective apoptosis-inducing agents in cancer therapy. Cancer
Lett 1996;110:63–70.
4. Trickler D, Shklar G, Schwartz J. Inhibition of oral carcinogenesis by
glutathione. Nutr Cancer 1993;20:139–44.
5. Julius M, Lang C, Gleiberman L, et al. Glutathione and morbidity in a
community-based sample of elderly. J Clin Epidemiol 1994;47:1021–6.
6. Hagen TM, Wierzbicka GT, Sillau AH, et al. Fate of dietary
glutathione: disposition in the gastrointestinal tract. Am J Physiol
1990;259(4Pt1):G530–5.
7. Favilli F, Marraccini P, Iantomasis T, Vincenzini MT. Effect of orally
administered glutathione on glutathione levels in some organs of rats: role of specific
transporters. Br J Nutr 1997;78:293–300.
8. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability
of oral glutathione. Eur J Clin Pharmacol 1992;43:667–9.
9. Hunjan MK, Evered DF. Absorption of glutathione from the
gastro-intestinal tract. Biochim Biophys Acta 1985;815:184–8.
10. Johnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red blood
cell glutathione in healthy adults. Am J Clin Nutr 1993;58:103–5.
11. Bunin AIa, Filina AA, Erchev VP. A glutathione deficiency in
open-angle glaucoma and the approaches to its correction. Vestn Oftalmol
1992;108:13–5 [in Russian].
12. Amores-Sanchez MI, Medina MA. Glutamine, as a precursor of
glutathione, and oxidative stress. Mol Genet Metab 1999;67:100–5.
13. Wang ST, Chen HW, Sheen LY, Lii CK. Methionine and cysteine affect
glutathione level, glutathione-related enzyme activities and the expression of glutathione
S-transferase isozymes in rat hepatocytes. J Nutr 1997;127:2135–41.
14. Vendemiale G, Altomare E, Trizio T, et al. Effects of oral
S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J
Gastroenterol 1989;24:407–15.
15. Bounous G, Gervais F, Amer V, et al. The influence of dietary whey
protein on tissue glutathione and the diseases of aging. Clin Invest Med
1989;12:343–9.
16. Molloy J, Martin JF, Baskerville PA, et al. S-nitrosoglutathione
reduces the rate of embolization in humans. Circulation 1998;98:1372–5.
17. Smyth JF, Bowman A, Perren T, et al. Glutathione reduces the toxicity
and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin:
results of a double-blind, randomised trial. Ann Oncol 1997;8:569–73.
18. Cascinu S, Cordella L, Del Ferro E, et al. Neuroprotective effect of
reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized
double-blind placebo-controlled trial. J Clin Oncol 1995;13:26–32.
19. Sechi G, Deledda MG, Bua G, et al. Reduced intravenous glutathione in
the treatment of early Parkinson’s disease. Prog Neuropsychopharmacol Biol
Psychiatry 1996;20:1159–70.
20. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ. Anti-oxidants show
an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci
1991;81:739–42.
21. Lenzi A, Picardo M, Gandini L, et al. Glutathione treatment of
dyspermia: effect on the lipoperoxidation process. Hum Reprod
1994;9:2044–50.
22. Lenzi A, Culasso F, Gandini L, et al. Placebo-controlled,
double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod
1993;8:1657–62.
23. Testa B, Mesolella M, Testa D. Glutathione in the upper respiratory
tract. Ann Otol Rhinol Laryngol 1995;104:117–9.
24. Dalhoff K, Ranek L, Mantoni M, Poulsen HE. Glutathione treatment of
hepatocellular carcinoma. Liver 1992;12:341–3.
25. Garcia-Giralt E, Perdereau B, Brixy F, et al. Preliminary study of
glutathione, L-cysteine and anthocyans (Recancostat Compositum™) in metastatic
colorectal carcinoma with malnutrition. Seventh International Congress on Anti-Cancer
Treatment, February 3–6, 1996, Paris, France.
26. Jones DP, Coates RJ, Flagg EW, et al. Glutathione in foods listed in
the National Cancer Institutes Health Habits and History Food Frequency Questionnaire.
Nutr Cancer 1995;17:57–75.
27. White AC, Thannickal VJ, Fanburg BL. Glutathione deficiency in human
disease. J Nutr Biochem 1994;5:218–26.